# Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/empagliflozin-a-sodium-glucose-co-transporter-2-inhibitor-alleviates-atrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qingmiao Shao,Lei Meng,Sharen Lee,Gary Tse,Mengqi Gong,Zhiwei Zhang,Jichao Zhao,Yungang Zhao,Guangping Li,Tong Liu |
| Citations | 295 |
| DOI | 10.1186/s12933-019-0964-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0964-4 |
| OpenAlex ID | https://openalex.org/W2989603136 |
| PMID | 31779619 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Zhiwei Zhang](https://scholariq.org/researchers/zhiwei-zhang/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.